|
A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients Clinical research trials and A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients. A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients clinical trial. Subjects frequently obtain the most expert healthcare possible for their A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients
A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients
For Condition: Herpes Simplex,HIV Infections
Status: Completed
Sponsor(s): Glaxo Wellcome ,
Synopsis: To determine the safety and efficacy of oral valacyclovir hydrochloride ( 256U87 ) compared to acyclovir in the treatment of recurrent anogenital herpes in HIV-infected patients with CD4 counts = or > 100 cells/mm3.
Details:
Eligibility:
Study Type: Interventional, Treatment, Safety Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Patients must have: - HIV infection with CD4 counts = or > 100 cells/mm3. - Documented culture of anogenital herpes simplex virus (HSV) within the last 5 years. - History of recurrent anogenital HSV infection, with a recurrence (with or without culture) within 1 year prior to study. Exclusion Criteria Co-existing Condition: Patients with the following symptoms and conditions are excluded: - Malabsorption or vomiting that would potentially limit the retention and absorption of oral therapy. Concurrent Medication: Excluded: - Systemic antiherpes medication. - Interferon. Patients with the following prior conditions are excluded: History of hypersensitivity to acyclovir.
Total Enrollment:
Location and Contact Information:
George Washington Univ Med Ctr
Washington D.C., District of Columbia, 20037
United States
AIDS Research Consortium of Atlanta
Atlanta, Georgia, 30308
United States
San Diego Naval Hosp
San Diego, California, 921345000
United States
Northwestern Memorial Hosp
Chicago, Illinois, 60611
United States
Regional Med Ctr at Memphis
Memphis, Tennessee, 38103
United States
Infectious Disease Med Group / Adult Immunology Clinic
Oakland, California, 94609
United States
Baylor College of Medicine / Texas Med Ctr
Houston, Texas, 77030
United States
Univ of Arizona / Health Science Ctr
Tucson, Arizona, 85724
United States
Dr Marcus Conant
San Francisco, California, 94115
United States
Combat Group
Los Angeles, California, 90028
United States
UCSD Med Ctr
San Diego, California, 92103
United States
Buckley Braffman Stern Med Associates
Philadelphia, Pennsylvania, 19107
United States
Baylor College of Medicine
Houston, Texas, 77030
United States
Univ TX Med Branch / Ctr for Clinical Studies
Nassau Bay, Texas, 77058
United States
Univ of Kansas School of Medicine
Wichita, Kansas, 67214
United States
Univ of Pittsburgh / Graduate School of Public Health
Pittsburgh, Pennsylvania, 15261
United States
Saint Vincent's Hosp and Med Ctr
New York City, New York, 10011
United States
Rush Presbyterian - Saint Luke's Med Ctr
Chicago, Illinois, 60612
United States
Mount Sinai Med Ctr
New York City, New York, 10029
United States
Univ of Missouri at Kansas City School of Medicine
Kansas City, Missouri, 64108
United States
Emory Univ School of Medicine
Atlanta, Georgia, 30303
United States
West Haven Veterans Administration Med Ctr
West Haven, Connecticut, 06516
United States
Whitman - Walker Clinic
Washington D.C., District of Columbia, 20009
United States
MacGregor Med Association
Houston, Texas, 77054
United States
Infectious Diseases Research Clinic / Indiana Univ Hosp
Indianapolis, Indiana, 46202
United States
Univ of Mississippi Med Ctr
Jackson, Mississippi, 39216
United States
Georgetown Univ Med Ctr
Washington D.C., District of Columbia, 20007
United States
Beth Israel Med Ctr
New York City, New York, 10003
United States
UCSF - San Francisco Gen Hosp
San Francisco, California, 94110
United States
Univ of Rochester Med Ctr
Rochester, New York, 14642
United States
St Paul Ramsey Med Ctr
St. Paul, Minnesota, 55101
United States
Univ of South Florida
St. Petersburg, Florida, 33705
United States
Univ TX Galveston Med Branch
Galveston, Texas, 77550
United States
Univ of Iowa Hosp & Clinic
Iowa City, Iowa, 52242
United States
UCI Med Ctr
Orange, California, 92668
United States
Thomas Audetta Clinic
Houston, Texas, 77006
United States
Univ of South Alabama
Mobile, Alabama, 36604
United States
Veterans Administration Med Ctr / Regional AIDS Program
Washington D.C., District of Columbia, 20422
United States
Med College of Virginia
Richmond, Virginia, 232980049
United States
Roger Williams Med Ctr
Providence, Rhode Island, 02908
United States
St Louis Univ
St. Louis, Missouri, 63104
United States
Univ of Maryland at Baltimore
Baltimore, Maryland, 21201
United States
Los Angeles County - USC Med Ctr
Los Angeles, California, 90033
United States
Dallas Associated Dermatologists
Dallas, Texas, 75246
United States
ViRx Inc
San Francisco, California, 94103
United States
Portland Veterans Adm Med Ctr / Rsch & Education Grp
Portland, Oregon, 97210
United States
Additional Information:
Study ID Numbers: 104B; 07
Study Start Date:
Record last reviewed: April 1996
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00002084
Other Hiv Infections Studies:
1. Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma
2. A Comparison of Two Ways to Manage Anti-HIV Treatment (The SMART Study)
3. A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis carinii Pneumonia in AIDS Patients
4. T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents
5. Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals
Related Studies:
Other HIV Infections Clinical Trials
Other Alabama Clinical Trials
Other Mobile Clinical Trials
A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients
|
|
|
|
|
|
|
|